Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UAU201606594UpriorityCriticalpatent/UA113279U/en
Publication of UA113279UpublicationCriticalpatent/UA113279U/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Комбінований лікарський засіб для лікування ішемічних уражень тканин містить пентоксифілін та допоміжні речовини. Він додатково містить 3-(2,2,2-триметилгідразиній)пропіонат у вигляді основи або будь-яких фармацевтично прийнятних солей.The combination drug for the treatment of ischemic tissue lesions contains pentoxifylline and excipients. It additionally contains 3- (2,2,2-trimethylhydrazine) propionate in the form of a base or any pharmaceutically acceptable salts.
UAU201606594U2016-06-162016-06-16
COMBINED MEDICINE FOR TREATMENT OF ISCHEMIC TISSUE DAMAGES
UA113279U
(en)
Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions